Dailypharm Live Search Close

Global pharmaceutical companies acquire radiopharmaceuticals

By Son, Hyung-Min | translator Kang, Shin-Kook

24.05.28 05:19:29

°¡³ª´Ù¶ó 0
Lily¡¤AstraZeneca¡¤Novartis acquired companies specializing in radiopharmaceuticals

Domestic biopharmaceutical companies have also begun development¡¦FutureChem has successfully entered a Phase 2 trial

The high interest in radiopharmaceuticals has led to investments by pharmaceutical companies. Last year and this year, Lily invested KRW 3.5 trillion in a company developing radiopharmaceuticals. Global pharmaceutical companies, including AstraZeneca, Novartis, and BMS, have acquired companies developing radiopharmaceuticals and entered the market. In South Korea, FutureChem and Dong-A ST are also developing radiopharmaceuticals and exploring opportunities for technology transfer and commercialization potential.

Radiopharmaceuticals work by delivering radioactive isotopes into the body, and then the isotopes release radio waves when reaching cancer cells, destroying cancer organs. Radiopharmaceuticals are

Son, Hyung-Min(shm@dailypharm.com)
If you want to see the full article, please JOIN US (click)